Antitumor activity of syngeneic/autologous graft-versus-host disease.
Hess
A D
AD
Oncology Center, Johns Hopkins University, Baltimore, MD 21287-8985, USA.
Kennedy
M J
MJ
Ruvolo
P P
PP
Vogelsang
G B
GB
Jones
R J
RJ
D000818:Animals; D016026:Bone Marrow Transplantation; D016572:Cyclosporine / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D014182:Transplantation, Autologous
D000949:Histocompatibility Antigens Class II; D016572:Cyclosporine